ABCC8 p.His125Gln
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 16442101
[PubMed]
Frelet A et al: "Insight in eukaryotic ABC transporter function by mutation analysis."
No.
Sentence
Comment
426
Shyng et al. [204] have reported that H125Q, N188S, F591L, T1139M, R1215Q and G1382S generated functional channels in the absence of ATP, indicating that the lack or reduction of KATP channel sensitivity to MgADP is a common molecular defect associated with the disease.
X
ABCC8 p.His125Gln 16442101:426:38
status: NEW
PMID: 9648840
[PubMed]
Shyng SL et al: "Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy."
No.
Sentence
Comment
2
We have studied the functional properties of novel SUR1 mutations identified in PHHI patients, including H125Q, N188S, F591L, T1139M, R1215Q, G1382S, and R1394H.
X
ABCC8 p.His125Gln 9648840:2:105
status: NEW3 R1394H and F1388 SUR1, a previously identified PHHI mutation, resulted in no functional channels when coexpressed with Kir6.2 in COS cells, while H125Q, N188S, F591L, T1139M, R1215Q, and G1382S SUR1 generated functional channels in the absence of ATP.
X
ABCC8 p.His125Gln 9648840:3:146
status: NEW4 With the exception of N188S and H125Q, all mutants had reduced response to stimulation by MgADP.
X
ABCC8 p.His125Gln 9648840:4:32
status: NEW75 The positions of the seven newly identified SUR1 mutations that are associated with the disease PHHI are shown in Fig. 1, including H125Q, N188S, F591L, T1139M, R1215Q, G1382S, and R1394H on both SUR1 topology models.
X
ABCC8 p.His125Gln 9648840:75:132
status: NEW90 The level of activity of other channels follows the order of WT ~N188S ~T1139M > G1382S > H125Q > F591L > R1215Q.
X
ABCC8 p.His125Gln 9648840:90:90
status: NEW112 Compared with wild-type channels, H125Q had a slightlygreater response to diazoxide (P < 0.1, ANOVA), N188S hada response that is similar to the wild-type channel (NS, ANOVA), T1139M and G1382S mutant channels had slightly reduced responses, while F591L and R1215Q channels had severely reduced responses (P < 0.005 and 0.025, respectively, ANOVA) (Fig. 6).
X
ABCC8 p.His125Gln 9648840:112:34
status: NEW131 Another patient, compound heterozygous for the H125Q mutation and the F1388 mutation, had clinically mild disease.
X
ABCC8 p.His125Gln 9648840:131:47
status: NEW132 The mild disease is consistent with the functional data of the H125Q mutation.
X
ABCC8 p.His125Gln 9648840:132:63
status: NEW156 With the exception of N188S and H125Q, which formed channels that were indistinguishable from the wild-type in terms of regulation of the channel by nucleotides and diazoxide, all other mutants caused defects of various severity in the resulting channels.
X
ABCC8 p.His125Gln 9648840:156:32
status: NEW162 Although for some mutations ( F1388, H125Q, R1215Q, R1394H) the in vitro findings correlate well with the clinical observations, in other mutations there seems to be a discrepancy between in vitro and clinical observations.
X
ABCC8 p.His125Gln 9648840:162:37
status: NEW175 Five others (H125Q, N188S, F591L, T1139M, and R1215Q) are outside of the predicted nucleotide-binding folds.
X
ABCC8 p.His125Gln 9648840:175:13
status: NEW176 However, except for N188S and H125Q, these mutations all show some defects in regulation of the channel by MgADP or by diazoxide.
X
ABCC8 p.His125Gln 9648840:176:30
status: NEW185 Pancreatectomy BV N188S 3992-3 c-to-g <1 week Severe No Pancreatectomy CB H125Q F1388 1 year Mild No Pancreatectomy Q R1215Q 3992-9 g-to-a <1 week Severe Inadequate Pancreatectomy AO R1394H 3992-9 g-to-a < week Severe No Pancreatectomy BI F591L - <1 week Mild Yes Diazoxide BU G1382S - <1 week Severe ??
X
ABCC8 p.His125Gln 9648840:185:74
status: NEW
No.
Sentence
Comment
63
Mutations within the SUR1 gene Patient Exon or intron Nucleotide changea Codona predicted effect Domainb Restriction site change Frequency (%) HI chromosomes (n = 88) Segregation demonstrated Frequency 200 normal chromosomes A1 exon 2 221G→A R74Q Tm PstI 1 (1.1%) NA 0 B2d exon3 375C→G H125Q Tm DdeIc 1 (1.1%) NA 0 C3e exon 4 563A→G N188S Tm TspRI 1 (1.1%) yes 0 D4 exon 6 949delC 317fs/ter Tm Bsp1286I 1 (1.1%) yes 0 E5 exon 8 1216A→G N406D Tm XcmI 1 (1.1%) NA 0 F6f intron 10 1630+1G→T aberrant splicing Tm BsrI 2 (2.3%) yes 0 G7 exon 12 1773C→G F591L Tm BsoF1 1 (1.1%) no 0 H8 exon 13 1893delT 631fs/ter Tm BstNI 1 (1.1%) yes 0 F6f intron 15 2117-1G→A aberrant splicing NBF-1 PstI 1 (1.1%) yes 0 I9 exon 24 2860C→T Q954X - BstNI 1 (1.1%) yes 0 J10g exon 28 3416C→Th T1139M Tm NlaIII 1 (1.1%) yes 0 K11 exon 29 3644G→A R1215Q Tm NciI 1 (1.1%) yes 0 J10g intron 32 3992-9G→Ai aberrant splicing NBF-2 NciI 4 (4.5%) yes 0 C3e intron 32 3992-3C→G aberrant splicing NBF-2 AvaI 1 (1.1%) yes 0 L12 exon 34 4135G→C G1379R NBF-2 EagI 1 (1.1%) yes 0 M13 exon 34 4144G→A G1382S NBF-2 BglI 1 (1.1%) yes 0 B2d exon 34 4162delTTCi,j delF 1388 NBF-2 BseRI 1 (1.1%) yes 0 J10g exon 34 4181G→Ah R1394H NBF-2 DraIII 1 (1.1%) yes 0 N14 exon 35 4310G→Ai aberrant splicing NBF-2 MspI 1 (1.1%) yes 0 O15 exon 37 4525insCGGCTT insertion of AlaSer ft d 1508 NBF-2 PvuIIk 1 (1.1%) yes 0 after codon 1508 aNucleotide and codon positions are according to the full-length human SUR1 cDNA sequence incorporating the alternative splicedform of exon 17 (GenBank accession nos L78208 and L78216).
X
ABCC8 p.His125Gln 9618169:63:300
status: NEW200 A model for SUR1 (29) predicts that the remaining seven missense mutations (Arg74Gln, His125Gln, Asn188Ser, Asn406Asp, Phe591Leu, Thr1139Met, Arg1215Gln) are located either within transmembrane segments or are present on the extracellular or cytoplasmic loops connecting adjacent trans- membranehelices.Theidentificationofthesemissensemutations in HI patients provides a basis for further studies to elucidate the functions of these transmembrane domains in SUR1 and KATP channel activity.
X
ABCC8 p.His125Gln 9618169:200:86
status: NEW201 We have found that the His125Gln, Phe591Leu, Thr1139Met and Arg1215Gln mutations result in various reductions in the sensitivity of KATP channels to stimulation by MgADP in vitro (S.-L.Shyng et al., unpublished data).
X
ABCC8 p.His125Gln 9618169:201:23
status: NEW233 To detect the His125Gln mutation, which did not alter a restriction enzyme site, PCR-directed site-specific mutagenesis was used to incorporate a DdeI restriction site into products derived from wild-type alleles.
X
ABCC8 p.His125Gln 9618169:233:14
status: NEW